Amylyx Pharmaceuticals, Inc. (NASDAQ:AMLX) is one of the best performing pharma stocks in 2025. Amylyx Pharmaceuticals, Inc.

Wegovy is now available as a daily pill, but experts say strict dosing schedules and more intense side effects may not make it a better option than the injection.

Patients can already access the first GLP-1 obesity pill from Novo Nordisk, and a rival oral drug from Eli Lilly is slated ...

While many have found success with medication, they are not a cure-all and experts caution they are not without risk.

GLP-1 meds are are highly effective at treating diabetes, obesity and other conditions. But when people stop using them, the ...

Novo Nordisk (NVO) downgraded to Hold after FDA GLP-1 actions and 2026 patent cliffs threaten Wegovy supply and growth. See ...

On Friday, Novo Nordisk (NVO) shares saw an increase in pre-market trading. This market movement is directly linked to a new initiative by Amazon’s digital pharmacy. The platform announced it ...

California and other states say the drugs are too costly, even as the Trump administration announces plans to lower prices.

According to an article posted by the Yale School of Medicine in July 2024, “The first drug in a class known as GLP-1 ...

President Donald Trump isn’t opposed to using weight-loss drugs. Trump, 79, addressed concerns about his health during a ...

His discovery of the protein fragment GLP-1 was crucial in the development of Ozempic, Wegovy and other blockbuster obesity ...